Windham Life Sciences Partners
SEC Form D filer · New York
Windham Life Sciences Partners filed an SEC Form D/A amendment on November 9, 2026 for Windham Life Sciences Partners IV, L.P., stating a total offering of $200M. The Windham Life Sciences Partners filing is under SEC CIK 1999637 and lists an address in New York, US. The filing names Adam E Fine and Windham Life Sciences Partners General Partner IV, LLC as related persons and reports $58.6M sold. As of November 9, 2026, DryPowder has not verified the Windham Life Sciences Partners thesis, check size or partners; this page shows only what the public filing says.
Updated · Source: SEC EDGAR
Filing facts FORM D
- Issuer on the filing
- Windham Life Sciences Partners IV, L.P.
- Firm
- Windham Life Sciences Partners
- SEC CIK
- 1999637
- Accession number
- 0001999637-26-000001
- Form type
- D/A (amendment to an earlier offering)
- Filed with the SEC
- Total offering amount
- $200M
- Address on filing
- New York, US
- Fund type on the filing
- Venture Capital Fund
- Organized
- Delaware, 2023
- Exemptions claimed
- Rule 506(b); Investment Company Act 3(c)(1) (limited number of beneficial owners); Investment Company Act 3(c)(7), qualified purchasers only
- Date of first sale
- Oct 27, 2023
- Amount sold at filing
- $58.6M
- Investors at filing
- 83
- Minimum LP commitment
- $1
- Partners
- Partner contacts appear once the profile is verified; the people the filing names are listed below.
People named on the filing FORM D
Related persons listed on the Form D: the executive officers, directors and promoters of the issuer or its general partner.
- Adam E Fine · Executive Officer, Promoter, Managing Member of General Partner
- Windham Life Sciences Partners General Partner IV, LLC · Director, General Partner
What this Form D tells a founder
A Form D is the notice a private fund files with the U.S. Securities and Exchange Commission when it sells interests under Regulation D. Venture firms file one for each new fund vehicle, usually within 15 days of the first sale to an investor, so a fresh filing is one of the earliest public signs that a firm is raising or has raised new capital.
This filing is an amendment (Form D/A), which updates an offering Windham Life Sciences Partners reported earlier; it does not by itself mean a new fund. The stated amount is the target the fund may raise, not money already committed, and the filing does not name the companies the fund will back or the size of its checks.
DryPowder reads every venture Form D from SEC EDGAR, drops single-deal SPVs, and ties each filing to the firm behind it. Once DryPowder verifies the Windham Life Sciences Partners website, stage, check size and partners, this page becomes a full profile.
Other funds that filed a Form D the same week
Looking for funds writing checks now?
See every fund that filed a Form D recently, or get matched with verified seed and pre-seed funds.
Sources
- SEC EDGAR: Form D/A, Windham Life Sciences Partners IV, L.P., filed
- Method: How DryPowder builds its data
Updated